Guy Goodwin
FMedSci
Emeritus Professor of Psychiatry
The development of better ways to treat mood disorders
My research interests are in the treatment of bipolar disorder and the application of neuroscience and technology in understanding the neurobiology of mood disorders, with a focus on developing new treatments.
I was formerly W.A.Handley Chair of Psychiatry and head of the University department of Psychiatry (1996-2011).
I am a Fellow of the American College of Neuropsychopharmacology, and have previously held the positions of President of the British Association for Psychopharmacology (2004–2005) and of the European College of Neuropsychopharmacology (ECNP, 2013-2016).
I am an Emeritus Senior Investigator on the faculty of UK National Institute for Health Research (NIHR).
I am a Thomson Reuters highly cited researcher (top 1% in field).
Recent publications
-
Psilocin acutely alters sleep-wake architecture and cortical brain activity in laboratory mice
Journal article
Thomas CW. et al, (2022), Translational Psychiatry, 12
-
Using a generative model of affect to characterize affective variability and its response to treatment in bipolar disorder
Journal article
Pulcu E. et al, (2022), Proceedings of the National Academy of Sciences, 119
-
Expert consensus recommendations on the use of randomized clinical trials for drug approval in psychiatry- comparing trial designs.
Journal article
Similon MVM. et al, (2022), Eur Neuropsychopharmacol, 60, 91 - 99
-
The costs of bipolar disorder in the United Kingdom.
Journal article
Simon J. et al, (2021), Brain Behav
-
Generalised Anxiety Disorder and Depression: Contemporary Treatment Approaches.
Journal article
Goodwin GM. and Stein DJ., (2021), Adv Ther